Cost-effectiveness analysis of improved blood pressure control of hypertensive patients with Type 2 diabetes mellitus

被引：0
|
作者：
Samira, HH
Lahiry, S
Howlader, SR
Parveen, S
Khan, AKA
机构：
[1] Univ Dhaka, Inst Hlth Econ, Dhaka, Bangladesh
[2] Diabet Assoc Bangladesh, Hlth Econ Unit, Dhaka, Bangladesh
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：A50 / A50
页数：1
相关论文
共 50 条
  • [1] Clinical and cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes mellitus
    Habib, Samira Humaira
    Akter, Salima
    Parveen, Shahanaz
    Biswas, Kazal Boron
    Saha, Soma
    Khan, A. K. Azad
    Howlader, Sushil Ranjan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2008, 2 (03) : 163 - 170
  • [2] Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
    Stearne, MR
    Palmer, SL
    Hammersley, MS
    Franklin, SL
    Spivey, RS
    Levy, JC
    Tidy, CR
    Bell, NJ
    Steemson, J
    Barrow, BA
    Coster, R
    Waring, K
    Nolan, L
    Truscott, E
    Walravens, N
    Cook, L
    Lampard, H
    Merle, C
    Parker, P
    McVittie, J
    Draisey, I
    Murchison, LE
    Brunt, AHE
    Williams, MJ
    Pearson, DW
    Petrie, XMP
    Lean, MEJ
    Walmsley, D
    Lyall, F
    Christie, E
    Church, J
    Thomson, E
    Farrow, A
    Stowers, JM
    Stowers, M
    McHardy, K
    Patterson, N
    Wright, AD
    Levi, NA
    Shearer, ACI
    Thompson, RJW
    Taylor, G
    Rayton, S
    Bradbury, M
    Glover, A
    Smyth-Osbourne, A
    Parkes, C
    Graham, J
    England, P
    Gyde, S
    BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7160): : 720 - 726
  • [3] CONTROL OF BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS TYPE 2
    Arshad, Abdul Rehman
    PAKISTAN HEART JOURNAL, 2014, 47 (02): : 78 - 83
  • [4] Screening for type 2 diabetes mellitus: A cost-effectiveness analysis
    Hoerger, TJ
    Harris, R
    Hicks, KA
    Donahue, K
    Sorensen, S
    Engelgau, M
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (09) : 689 - 699
  • [5] Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus
    Oliveira Goncalves, Ana Carolina
    Cazarim, Maurilio de Souza
    Sanches, Cristina
    Leira Pereira, Leonardo Regis
    Tome Camargos, Ana Marcia
    Aquino, Jessica Azevedo
    Baldoni, Andre Oliveira
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [6] Cost-Effectiveness Of Drug Compliance In Type 2 Diabetes Mellitus Patients
    Maciel, Olga
    Vera, Zully
    Marin, Gustavo H.
    Morinigo, Macarena
    Maidana, Mabel
    Mastroianni, Patricia
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (05): : 1824 - 1829
  • [7] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA
    Rodriguez, L.
    Lew, D.
    VALUE IN HEALTH, 2020, 23 : S115 - S115
  • [8] Cost-effectiveness analysis of intensive blood glucose control in patients with Type 2 diabetes in Bangladesh.
    Samira, HH
    Lahiry, S
    Sayeed, MA
    Khan, AKA
    DIABETOLOGIA, 2003, 46 : A435 - A435
  • [9] A Bayesian approach to stochastic cost-effectiveness analysis -: An illustration and application to blood pressure control in type 2 diabetes
    Briggs, AH
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2001, 17 (01) : 69 - 82
  • [10] Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus
    Li, Jing
    Sun, Li
    Hou, Yabing
    Chen, Liming
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
12345